Latest renal failure Stories
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing.
University of Cincinnati researchers have discovered a new genetic target for diuretic therapy in patients with fluid overload, such as those with congestive heart failure, liver cirrhosis or kidney failure.
A kidney transplant is the best treatment for kidney failure, which afflicts 2 million people worldwide.
Drugs commonly prescribed to patients with chronic kidney disease (CKD) may not be as strongly effective as once thought, and may cause unexpected harm to blood vessels.
For children receiving kidney transplants, a potentially correctable blood condition present in about one in four recipients is associated with a moderately increased risk of the graft's later failure, suggesting that clinicians should weigh whether transplant is advisable when the condition is present.
Draper Laboratory is designing a microdevice that will provide a more biologically realistic growth environment for human kidney cells
In a study that included nearly 2 millions adults in Canada, the rate of progression to untreated kidney failure was considerably higher among older adults.
An estimated 26 million American adults suffer with chronic kidney disease (CKD), and according to a new study, many cases are left untreated, especially among the elderly.